Vulval cancer
Results
Phase 2
This trial was looking at Veregen cream to treat pre cancerous changes to the skin of the vulva.
Vulval intraepithelial neoplasia (VIN) means there are pre cancerous changes to cells in the skin of the vulva. It is not cancer, but if it isn’t treated it can develop into vulval cancer. There are 3 categories of VIN. This trial was for women with VIN 3, which means the cells are very abnormal. Your doctor may also call this severe dysplasia.
This trial was open for people to join between 2014 and 2017. The team published the results in 2020.
Recruitment start: 18 September 2014
Recruitment end: 9 June 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Luesley
NIHR Clinical Research Network: Cancer
University of Birmingham
Sandwell and West Birmingham Hospitals NHS Trust
NIHR Research for Patient Benefit (RfPB) programme
Last reviewed: 4 November 2021
CRUK internal database number: 11782
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
